43,056 Registered Patient Population |
0.14% of Total Population Represented by Patients |
3 Total Medical Retail Locations Currently in Operation |
1,435,200 : 1 Patients : Retail |
CBD treatment is legal in Texas. Patients with severe epilepsy may seek a doctor’s recommendation for cannabis oil with no more than 1 percent THC. The state has authorized dispensing organizations to cultivate, process, and distribute this medicine.
Patient Rights and Civil Protections |
29/100 |
|
Arrest Protection |
12/25 |
Affirmative Defense |
12/20 |
Parental Rights Protections |
0/20 |
DUI Protections |
0/10 |
Employment Protections |
0/20 |
Explicit Privacy Standards |
5/5 |
|
Access to Medicine |
12/100 |
|
Authorizes Retail Access |
10/10 |
Alternative Accessibility Methods |
2/20 |
- Authorizes Delivery |
2/10 |
- Authorizes Curbside Pickup |
0/10 |
Personal Cultivation |
0/15 |
Collective Gardening |
0/5 |
Sufficient Number of Licenced Retailers |
0/30 |
Reciprocity |
0/20 |
|
Program Functionality |
48/100 |
|
Legal Protections Within Reasonable Time Frame |
16/20 |
Reasonable Possession Limits |
10/10 |
Reasonable Purchase Limits |
0/10 |
Telemedicine for Physician Certifications |
15/15 |
Patient and Physician Representation in Program Decision Making |
0/20 |
Reasonable Caregiver Standards |
0/5 |
- Background Checks |
0/2 |
- Number of Caregivers |
0/3 |
Reasonable Physician Standards |
3/5 |
Access to Administration Methods |
1/10 |
- Allows Dried Flower |
0/5 |
- Allows Edibles, Concentrates, and Other Forms |
1/5 |
Provides Access to Minors on School Grounds |
3/5 |
|
Affordability |
40/100 |
|
Sales Tax Break for Patients and Caregivers |
0/20 |
Covered by State Insurance or Health Aid |
0/20 |
Reasonable Registration Fees |
20/20 |
Financial Hardship Waivers or Discounts |
20/20 |
Donation Program |
0/10 |
Allows Multi-Year Registrations |
0/10 |
|
Health and Social Equity |
42/100 |
|
State Program Protections |
25/25 |
Housing Protections |
0/25 |
Access for Minors |
10/10 |
Access in Underserved Areas |
0/10 |
List of Qualifying Conditions is Exhaustive or All Inclusive |
7/10 |
Allows Patients to Medicate Where they Choose |
0/10 |
Organ Transplants |
0/5 |
Ownership or Employment Restrictions |
0/5 |
|
Consumer Protection and Product Safety |
42/200 |
|
Cultivation Operations |
14/50 |
Quality Management Systems |
5/10 |
Staff Training |
0/10 |
Standard Operating Procedures |
3/8 |
- Facility and Equipment Sanitation |
0/1 |
- Workplace Safety |
1/1 |
- Storage |
0/1 |
- Batch and Lot Tracking |
1/1 |
- Security |
1/1 |
- Waste Disposal |
0/1 |
- Water Management |
0/1 |
- Records Management |
0/1 |
Pesticide Usage Limitations |
2/2 |
Environmental Impact Regulations |
0/2 |
Required Testing |
0/8 |
- Cannabinoids |
0/1 |
- Terpenes |
0/1 |
- Microbials |
0/1 |
- Aflatoxins |
0/1 |
- Pesticides |
0/1 |
- Heavy Metals |
0/1 |
- Foreign Matter |
0/1 |
- Moisture Content/ Water Activity |
0/1 |
Packaging and Labeling |
1/3 |
- Cannabinoids |
1/1 |
- Terpenes |
0/1 |
- Pesticides |
0/1 |
Complaints, Adverse Event Reporting, and Recall Protocol |
3/7 |
Manufacturing Operations |
15/50 |
Quality Management Systems |
5/10 |
Staff Training |
3/10 |
Standard Operating Procedures |
3/7 |
- Facility and Equipment Sanitation |
0/1 |
- Workplace Safety |
1/1 |
- Storage |
0/1 |
- Batch and Lot Tracking |
1/1 |
- Security |
1/1 |
- Waste Disposal |
0/1 |
- Records Management |
0/1 |
Environmental Impact Regulations |
0/3 |
Required Testing |
0/10 |
- Cannabinoids |
0/1 |
- Terpenes |
0/1 |
- Microbials |
0/1 |
- Aflatoxins |
0/1 |
- Pesticides |
0/1 |
- Heavy Metals |
0/1 |
- Residual Solvents |
0/1 |
- Homogeneity |
0/1 |
- Foreign Matter |
0/1 |
- Water Activity |
0/1 |
Packaging and Labeling |
1/5 |
- Cannabinoids |
1/1 |
- Terpenes |
0/1 |
- Ingredients |
0/1 |
- Allergens |
0/1 |
- Nutritional Content |
0/1 |
Complaints, Adverse Event Reporting and Recall Protocol |
3/5 |
Dispensary Operations |
10/50 |
Staff Training |
0/20 |
Standard Operating Procedures |
3/7 |
- Facility Sanitation |
0/1 |
- Workplace Safety |
1/1 |
- Storage |
0/1 |
- Batch and Lot Tracking |
1/1 |
- Security |
1/1 |
- Waste Disposal |
0/1 |
- Records Management |
0/1 |
Product Testing |
0/10 |
- Product Meets Requirements Before Sale |
0/5 |
- COA Disclosure |
0/5 |
Complaints, Adverse Event Reporting and Recall Protocol |
7/13 |
Laboratory Operations |
3/50 |
Independent or Third-Party |
0/5 |
Laboratory Sampling |
0/5 |
Method Validation |
0/4 |
Quality Management Systems |
0/5 |
Staff Training |
0/20 |
Standard Operating Procedures |
3/7 |
- Facility and Equipment Sanitation |
0/1 |
- Equipment and Instrument Calibration |
0/1 |
- Workplace Safety |
1/1 |
- Sample Tracking |
1/1 |
- Security |
1/1 |
- Waste Disposal |
0/1 |
- Records Management |
0/1 |
Result Reporting |
0/4 |
|
Score Penalties |
30/100 |
|
Gives Regulatory Preference to Adult Use |
0/20 |
Classifies Cannabis as a Medicine of Last Resort |
0/15 |
Administrative or Supply Problems |
5/15 |
Requires Vertical Integration |
10/10 |
Creates New Criminal Penalties for Patients |
0/10 |
Limits Patients to a Single Retailer |
0/10 |
No System for Adding Qualifying Conditions |
10/10 |
Imposes Bans or Limits on THC |
5/5 |
Imposes Bans or Limits on CBD |
0/5 |
|
Excerpted from ASA's 2022 State of the States Report. |